GeneThera

United States
Calexico, California, United States, 80021

Company profile

GeneThera company profile

GeneThera is a biotechnology company, dedicated to improving food safety by applying the latest molecular technologies to eradicate "cross over"(zoonotic) diseases such as Johne's Disease, Mad Cow Disease, Chronic Wasting Disease, and E.coli. Diseases of terrestrial, avian and aquatic life animals influence a number of economic and global security issues; food for an increasing world population, access to international trade, species conservation and protection of those endangered, and economic growth in developing and re-organizing nations. Because many animal disease agents are zoonotic (transmissible between humans and animals, causing infection in both species), their management and prevention are crucial to improving public health on a global scale. The company focuses on developing molecular diagnostic tests, therapeutics, and vaccines in the belief that better technologies and methodology need to be implemented to help control emerging diseases in animals and in humans, if not these diseases in animals will likely continue to cause serious and growing problems in terms of economics, human health and biodiversity.

Business identity

Contact email
[email protected]
Phone number
303-439-2085
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
1998-01-01

Headquarters

Postal code
80021
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
1
Total equity funding
$396,000
Last funding
Post IPO Equity / $396,000 / 2021-02-10
Last equity funding
Post IPO Equity / $396,000
Founders
1
Articles
2
Exited on
2000-12-29

Founders and investors

Founders

Tony Milici